Native Bio-Lenticules Mediated Rapamycin Delivery for Corneal Immunomodulation and Tissue Repair Promotion
Source abstract
Abstract
Corneal damage-related disorders, characterized by stromal opacity due to trauma, infection, or other etiologies, remain a major cause of visual impairment. Despite therapeutic advances, the scarcity of donor corneal grafts and the complexity of immune regulation continue to pose critical challenges. To address these limitations, we developed a novel immunomodulatory biomaterial composed of decellularized human stromal lenticules and rapamycin (RAPA) solubilized with deep eutectic solvents. Designed for interlamellar corneal implantation, this drug-loaded construct enables localized, sustained delivery of RAPA, exerting potent immunosuppressive and anti-inflammatory effects. In vitro, the RAPA-loaded lenticules maintained high transparency comparable to native human cornea and achieved controlled drug release for over 35 days. Additionally, the drug incorporation process enhanced both the biomechanical strength and the biocompatibility of the lenticules. Following interstromal transplantation into rabbit corneas, 1% RAPA-loaded grafts preserved corneal clarity for more than one month without triggering observable immune rejection. Histological evaluation confirmed the presence of neuronal markers within the grafts, indicating successful host-mediated nerve regeneration and a favorable balance between immune modulation and tissue repair. Collectively, these findings demonstrate that RAPA-loaded lenticules function as transparent, biomechanically robust, and immunosuppressive grafts with a strong potential for clinical translation in the treatment of corneal injuries and immune-mediated disorders.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Corneal Surgery and Treatments · Corneal surgery and disorders · Ocular Surface and Contact Lens
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Aier Academy of Ophthalmology
Central South University
Aier Eye Hospital
Jinan University
School of Medicine
Northwest University
Changsha Aier Eye Hospital
Aier Eye Institute
Xi’an Aier Eye Hospital
Xi’an People’s Hospital: Xi’an Fourth Hospital
Funding
Natural Science Foundation of Hunan Province · Aier Eye Institute · AIER Eye Group
References (91)
Show source-provided references
1. 10.1016/j.preteyeres.2019.10078010.1016/j.preteyeres.2019.100780 ↗
2. 10.1016/j.preteyeres.2015.07.00210.1016/j.preteyeres.2015.07.002 ↗
3. 10.1056/NEJM19980423338170210.1056/NEJM199804233381702 ↗
4. 10.3390/cells1005125410.3390/cells10051254 ↗
5. 10.3390/pharmaceutics1412279710.3390/pharmaceutics14122797 ↗
6. 10.1002/adfm.20231224310.1002/adfm.202312243 ↗
7. 10.1002/adma.20240176310.1002/adma.202401763 ↗
8. 10.1039/D5TB00090D10.1039/D5TB00090D ↗
9. 10.1016/S0039-6257(97)00119-710.1016/S0039-6257(97)00119-7 ↗
10. 10.3928/1081597X-20200826-0110.3928/1081597X-20200826-01 ↗
11. 10.1021/acsnano.5c0460610.1021/acsnano.5c04606 ↗
12. 10.1016/j.survophthal.2007.04.00810.1016/j.survophthal.2007.04.008 ↗
13. 10.1002/smll.20231046110.1002/smll.202310461 ↗
14. 10.1371/journal.pone.029581310.1371/journal.pone.0295813 ↗
15. 10.1111/xen.1280210.1111/xen.12802 ↗
16. 10.3389/fimmu.2018.0228310.3389/fimmu.2018.02283 ↗
17. 10.1016/j.ajt.2023.05.01710.1016/j.ajt.2023.05.017 ↗
18. 10.1371/journal.pone.018462810.1371/journal.pone.0184628 ↗
19. 10.1089/omi.2019.014310.1089/omi.2019.0143 ↗
20. 10.1038/s41572-024-00565-310.1038/s41572-024-00565-3 ↗
21. 10.1016/j.cytogfr.2023.06.00210.1016/j.cytogfr.2023.06.002 ↗
22. 10.1039/C9TB00912D10.1039/C9TB00912D ↗
23. 10.1039/D4NR05298F10.1039/D4NR05298F ↗
24. 10.1016/j.ijbiomac.2025.14324410.1016/j.ijbiomac.2025.143244 ↗
25. 10.1016/j.actbio.2017.08.04810.1016/j.actbio.2017.08.048 ↗
26. 10.1088/1748-605X/acb67b10.1088/1748-605X/acb67b ↗
27. 10.3389/fbioe.2022.88741410.3389/fbioe.2022.887414 ↗
28. 10.1002/adfm.20230485610.1002/adfm.202304856 ↗
29. 10.1016/j.preteyeres.2015.07.00110.1016/j.preteyeres.2015.07.001 ↗
30. 10.1016/j.exer.2010.06.02110.1016/j.exer.2010.06.021 ↗
31. 10.1016/S2214-109X(17)30393-510.1016/S2214-109X(17)30393-5 ↗
32. Whitcher J. P. · Bull. World Health Organ. · 2001 · 79 · 214
33. 10.1016/S0140-6736(12)60437-110.1016/S0140-6736(12)60437-1 ↗
34. 10.1001/jamaophthalmol.2015.477610.1001/jamaophthalmol.2015.4776 ↗
35. 10.1016/j.actbio.2018.08.01710.1016/j.actbio.2018.08.017 ↗
36. 10.1016/j.exer.2020.10831410.1016/j.exer.2020.108314 ↗
37. 10.1016/j.biomaterials.2020.11988010.1016/j.biomaterials.2020.119880 ↗
38. 10.1016/j.msec.2020.11167310.1016/j.msec.2020.111673 ↗
39. 10.1016/j.isci.2024.11068910.1016/j.isci.2024.110689 ↗
40. 10.1016/S0161-6420(13)31253-610.1016/S0161-6420(13)31253-6 ↗
41. 10.1016/j.biomaterials.2022.12143610.1016/j.biomaterials.2022.121436 ↗
42. 10.1016/j.bioactmat.2021.09.01410.1016/j.bioactmat.2021.09.014 ↗
43. 10.1002/advs.20230365010.1002/advs.202303650 ↗
44. 10.1016/j.actbio.2019.05.01710.1016/j.actbio.2019.05.017 ↗
45. 10.1186/s13287-025-04463-710.1186/s13287-025-04463-7 ↗
46. 10.1016/j.bioactmat.2021.02.00210.1016/j.bioactmat.2021.02.002 ↗
47. 10.1002/adhm.20160008610.1002/adhm.201600086 ↗
48. 10.3389/fphar.2021.79493910.3389/fphar.2021.794939 ↗
49. 10.1016/j.matt.2022.05.01810.1016/j.matt.2022.05.018 ↗
50. 10.1002/adma.20210986510.1002/adma.202109865 ↗
51. 10.1021/acsnano.4c1628010.1021/acsnano.4c16280 ↗
52. 10.3390/jfb1302005210.3390/jfb13020052 ↗
53. 10.1038/s41467-019-12803-410.1038/s41467-019-12803-4 ↗
54. 10.1002/adhm.20240256710.1002/adhm.202402567 ↗
55. 10.1016/0042-6989(94)90146-510.1016/0042-6989(94)90146-5 ↗
56. Algvere P. V. · Invest. Ophthalmol. Visual Sci. · 1993 · 34 · 349
57. 10.3390/ijms25181022710.3390/ijms251810227 ↗
58. 10.1016/j.bioactmat.2021.07.00110.1016/j.bioactmat.2021.07.001 ↗
59. 10.1016/j.ajo.2020.12.02010.1016/j.ajo.2020.12.020 ↗
60. 10.1002/jbm.a.3462410.1002/jbm.a.34624 ↗
61. 10.1002/adma.20240813610.1002/adma.202408136 ↗
62. 10.3928/1081597X-20101214-0210.3928/1081597X-20101214-02 ↗
63. 10.1007/s00198-009-1066-z10.1007/s00198-009-1066-z ↗
64. 10.1074/jbc.M50073320010.1074/jbc.M500733200 ↗
65. 10.1016/j.jmbbm.2023.10587010.1016/j.jmbbm.2023.105870 ↗
66. 10.1016/j.exer.2020.10810910.1016/j.exer.2020.108109 ↗
67. 10.1016/j.actbio.2022.08.01510.1016/j.actbio.2022.08.015 ↗
68. 10.1021/acsami.0c0189310.1021/acsami.0c01893 ↗
69. 10.1186/1756-9966-30-2810.1186/1756-9966-30-28 ↗
70. 10.1002/advs.20240802110.1002/advs.202408021 ↗
71. 10.1016/j.colsurfb.2016.03.08010.1016/j.colsurfb.2016.03.080 ↗
72. 10.1038/srep4125710.1038/srep41257 ↗
73. 10.1016/j.chemosphere.2018.06.10310.1016/j.chemosphere.2018.06.103 ↗
74. 10.1038/s41433-025-03898-910.1038/s41433-025-03898-9 ↗
75. 10.1117/1.JBO.26.4.04301010.1117/1.JBO.26.4.043010 ↗
76. 10.1007/s10439-014-0996-610.1007/s10439-014-0996-6 ↗
77. 10.1167/iovs.14-1445010.1167/iovs.14-14450 ↗
78. 10.3389/fbioe.2024.132361210.3389/fbioe.2024.1323612 ↗
79. 10.1016/S0140-6736(23)01349-110.1016/S0140-6736(23)01349-1 ↗
80. 10.1016/j.ajo.2005.07.02410.1016/j.ajo.2005.07.024 ↗
81. 10.1161/01.RES.76.3.41210.1161/01.RES.76.3.412 ↗
82. 10.1053/jhep.2002.3616010.1053/jhep.2002.36160 ↗
83. 10.1161/CIRCULATIONAHA.104.51670810.1161/CIRCULATIONAHA.104.516708 ↗
84. 10.1097/TP.0b013e3181ea391e10.1097/TP.0b013e3181ea391e ↗
85. 10.1038/nrrheum.2012.18110.1038/nrrheum.2012.181 ↗
86. 10.1111/ajt.1315810.1111/ajt.13158 ↗
87. 10.1016/j.actbio.2020.02.00310.1016/j.actbio.2020.02.003 ↗
88. 10.1186/s13063-022-06851-310.1186/s13063-022-06851-3 ↗
89. 10.3389/fbioe.2021.70948810.3389/fbioe.2021.709488 ↗
90. 10.1167/iovs.64.10.2710.1167/iovs.64.10.27 ↗
91. 10.1007/s11012-016-0416-010.1007/s11012-016-0416-0 ↗